RS20171030A1 - F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija - Google Patents

F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija

Info

Publication number
RS20171030A1
RS20171030A1 RS20171030A RSP20171030A RS20171030A1 RS 20171030 A1 RS20171030 A1 RS 20171030A1 RS 20171030 A RS20171030 A RS 20171030A RS P20171030 A RSP20171030 A RS P20171030A RS 20171030 A1 RS20171030 A1 RS 20171030A1
Authority
RS
Serbia
Prior art keywords
desulfated
fucoidan
fucose
oligo
inhibitors
Prior art date
Application number
RS20171030A
Other languages
English (en)
Inventor
Bojan Pavlović
Franz-Georg Prof Dr Hanisch
Cem Dr Aydogan
Original Assignee
Pavlovic Bojan
Hanisch Franz Georg Prof Dr
Cem Dr Aydogan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavlovic Bojan, Hanisch Franz Georg Prof Dr, Cem Dr Aydogan filed Critical Pavlovic Bojan
Priority to RS20171030A priority Critical patent/RS20171030A1/sr
Priority to EP18825803.2A priority patent/EP3694892A2/en
Priority to JP2020541639A priority patent/JP2020537032A/ja
Priority to US16/755,601 priority patent/US11608389B2/en
Priority to PCT/RS2018/000016 priority patent/WO2019074387A2/en
Publication of RS20171030A1 publication Critical patent/RS20171030A1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
RS20171030A 2017-10-12 2017-10-12 F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija RS20171030A1 (sr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
RS20171030A RS20171030A1 (sr) 2017-10-12 2017-10-12 F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija
EP18825803.2A EP3694892A2 (en) 2017-10-12 2018-10-05 F-fucoidan, desulfated f-fucoidan, and its processed derivatives in terms of desulfated oligo-fucose as inhibitors of gastrointestinal infection
JP2020541639A JP2020537032A (ja) 2017-10-12 2018-10-05 消化管感染阻害剤としてのｆ−フコイダン、脱硫酸化ｆ−フコイダンおよび脱硫酸化オリゴ−フコースの形に加工されたその誘導体
US16/755,601 US11608389B2 (en) 2017-10-12 2018-10-05 F-fucoidan, desulfated F-fucoidan, and its processed derivatives in terms of desulfated oligo-fucose as inhibitors of gastrointestinal infection
PCT/RS2018/000016 WO2019074387A2 (en) 2017-10-12 2018-10-05 F-FUCOIDAN, DEULFATED F-FUCOIDAN AND ITS DERIVATIVES TREATED IN THE FORM OF DESULPHATED OLIGO-FUCOSIS AS INHIBITORS OF GASTROINTESTINAL INFECTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RS20171030A RS20171030A1 (sr) 2017-10-12 2017-10-12 F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija

Publications (1)

Publication Number Publication Date
RS20171030A1 true RS20171030A1 (sr) 2019-04-30

Family

ID=64755690

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20171030A RS20171030A1 (sr) 2017-10-12 2017-10-12 F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija

Country Status (5)

Country Link
US (1) US11608389B2 (sr)
EP (1) EP3694892A2 (sr)
JP (1) JP2020537032A (sr)
RS (1) RS20171030A1 (sr)
WO (1) WO2019074387A2 (sr)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS497209B2 (sr) 1971-09-16 1974-02-19
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
US5459257A (en) 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
WO1996001278A1 (fr) 1994-07-01 1996-01-18 Seikagaku Corporation Procede pour produire un polysaccharide desulfate et une heparine desulfatee
US5646130A (en) 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
US6126961A (en) 1998-04-13 2000-10-03 Kross; Robert D. Composition and method for reducing the colonization of animal intestines by salmonella and other bacterial pathogens
US20020019991A1 (en) 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
WO2003062412A1 (fr) 2002-01-18 2003-07-31 Takara Bio Inc. Fucane sulfate
KR100485686B1 (ko) 2003-06-24 2005-04-28 학교법인 인제학원 참다시마 유래 올리고당의 제조방법
US7893041B2 (en) 2003-12-05 2011-02-22 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
WO2006015115A2 (en) 2004-07-30 2006-02-09 University Of Mississippi Potent immunostimulatory extracts from microalgae
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210697A1 (en) 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
KR20090127785A (ko) 2008-06-09 2009-12-14 박응렬 다시마 주요성분을 적절히 분리 추출, 농축, 전부 활용,오염을 유발하지 않는 다시마 완전 처리공정
JP5364352B2 (ja) * 2008-11-20 2013-12-11 国立大学法人鳥取大学 新規なフコイダン資化性微生物
WO2010120682A1 (en) 2009-04-13 2010-10-21 Morrow Ardythe L Milk oligosaccharide compositions and use thereof in treating infection in animals
PL2432478T3 (pl) 2009-05-21 2022-01-17 Bioatlantis Ltd Poprawa stanu, odporności i wydajności przewodu pokarmowego poprzez interwencję żywieniową
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
CN102274247B (zh) 2011-07-19 2013-03-13 南通大学 海带多糖胶囊及其制备方法和用途
CN102367282B (zh) 2011-10-20 2013-04-10 广东中烟工业有限责任公司 一种海带多糖及其制备方法和应用
CN102417549B (zh) 2011-11-07 2013-07-24 沈阳科思高科技有限公司 一种基于微波化学的褐藻活性多糖的提取方法
CN102936293B (zh) 2012-11-28 2016-01-20 天津科百生物科技研发有限公司 一种岩藻聚糖硫酸酯的提取纯化方法
DK2769726T3 (en) 2013-02-21 2019-02-25 Jennewein Biotechnologie Gmbh Synthetic or recombinant fucosylated oligosaccharides for use in the treatment of infections
AP2015008861A0 (en) 2013-04-19 2015-11-30 Actigenomics Sa Composition for enhancing immunity
CN103665120A (zh) 2013-11-19 2014-03-26 大连海洋大学 海带凝集素粗提取液的提取方法
CN105147743B (zh) 2015-06-18 2019-01-22 山东省医学科学院基础医学研究所 海带/海带多糖提取物在制备抗ev71药物中的应用

Also Published As

Publication number Publication date
WO2019074387A3 (en) 2019-05-31
JP2020537032A (ja) 2020-12-17
EP3694892A2 (en) 2020-08-19
US11608389B2 (en) 2023-03-21
WO2019074387A2 (en) 2019-04-18
US20210017301A1 (en) 2021-01-21

Similar Documents

Publication Publication Date Title
HK1249030A1 (zh) 化合物及在治療衰老相關病症中的用途
IL261167A (en) Heteroaryl pad4 inhibitors
IL255613A (en) The heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer
EP3389658A4 (en) GLYCOSIDASE INHIBITORS AND USES THEREOF
EP3454945A4 (en) ASH1L INHIBITORS AND METHODS OF TREATMENT THEREOF
EP3344624B8 (en) Tyk2 inhibitors and uses thereof
EP3331530A4 (en) Mthfd2 inhibitors and uses thereof
EP3262049A4 (en) Tyk2 inhibitors and uses thereof
GB2547402B (en) Prevention and treatment of microbial infections
EP3341007A4 (en) MALT1 INHIBITORS AND USES THEREOF
IL259796A (en) Aza-benzimidazole inhibitors of pad4
IL272649A (en) AHR inhibitors and their uses
EP3706737A4 (en) ASH11 INHIBITORS AND METHOD OF TREATING THEREOF
IL258513B (en) History of quinoxaline and pyridopyrazine as pi3k inhibitors in the cell
HK1250926A1 (zh) 抑制劑及其應用
HK1250028A1 (zh) 2-苯基-6-咪唑基-吡啶-4-甲酰胺衍生物及其作為eaat3抑制劑的用途
PL3362450T3 (pl) N1 i n7-podstawione pochodne sybiriliny oraz ich zastosowania jako inhibitory nekroptozy komórkowej
RS20171030A1 (sr) F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija
EP3468592A4 (en) COMPOSITIONS AND METHODS FOR TREATING ARENAVIRUS INFECTIONS
EP3242664A4 (en) Compositions and methods for treating gastrointestinal infections
IL269598A (en) History of quinoxaline and pyridopyrazine as PI3K-inhibitors in the cell
GB201519483D0 (en) Prevention and treatment of microbial infections
GB201518252D0 (en) Prevention and treatment of microbial infections
GB201513047D0 (en) Prevention and treatment of microbial infections
GB201511576D0 (en) Prevention and treatment of microbial infections